Predictive Value of Selenoprotein P in Newly Diagnosed Type 2 Diabetes: A Diagnostic Accuracy Study
Endocrinology Research and Practice · 06.07.2026 · 30 (3)
DOI: 10.5152/erp.2026.25896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology Research and Practice, online erschienen am 06.07.2026. Verfasst von Gürkan Yarbaş und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
To investigate levels of selenoprotein P (SeP), a liver-derived hepatokine, in patients with newly diagnosed type 2 diabetes mellitus (T2DM) compared with healthy controls and to evaluate its relationship with metabolic indicators.
Methods
Thirty-nine newly diagnosed T2DM patients and 41 healthy controls were enrolled between November 2024 and April 2025. Demographic and biochemical data were collected, and statistical analyses were conducted to assess the associations between SeP and glycemic and metabolic parameters.
Results
Selenoprotein P levels were significantly higher in the diabetic group (3.40 μg/mL) than in controls (2.79 μg/mL) with a p-value of .041. SeP showed positive associations with BMI (p = .021) and triglycerides (p = .008). There was a significant positive correlation between SeP and the TyG index in the whole group (Spearman r = .370, p < .001) and in the T2DM group (r = .395, p = .014). The diagnostic ability (AUC) of SeP was 0.633 (p = .041) with a cut-off of 2.861, showing 76.9% sensitivity and 53.7% specificity.
Conclusion
Serum selenoprotein P levels were elevated in patients with newly diagnosed type 2 diabetes mellitus and were associated with body mass index and triglyceride levels. Further studies are needed to clarify the clinical significance of these findings. Cite this article as: Yarbas G, Ucar C, Baylan FA, Yildizgoren MT. Predictive value of selenoprotein P in newly diagnosed type 2 diabetes: A diagnostic accuracy study. Endocrinol Res Pract. 2026;30(3):167-170.
Zitieren
APA
Yarbaş, G., Uçar, C., Baylan, F. A., & Yıldızgören, M. T. (2026). Predictive Value of Selenoprotein P in Newly Diagnosed Type 2 Diabetes: A Diagnostic Accuracy Study. Endocrinology Research and Practice, 30(3). https://doi.org/10.5152/erp.2026.25896
Vancouver
Yarbaş G, Uçar C, Baylan FA, Yıldızgören MT. Predictive Value of Selenoprotein P in Newly Diagnosed Type 2 Diabetes: A Diagnostic Accuracy Study. Endocrinology Research and Practice. 2026;30(3). doi:10.5152/erp.2026.25896
BibTeX
@article{Yarba2026,
author = {Yarbaş, Gürkan and Uçar, Cahit and Baylan, Filiz Alkan and Yıldızgören, Mustafa Turgut},
title = {Predictive Value of Selenoprotein P in Newly Diagnosed Type 2 Diabetes: A Diagnostic Accuracy Study},
journal = {Endocrinology Research and Practice},
year = {2026},
volume = {30},
number = {3},
doi = {10.5152/erp.2026.25896}
}
EUVIMED